Epidemiology of methicillin-resistant Staphylococcus aureus in Southern Stockholm, 2000-2003

Göran Hedin1, Hong Fang

  • 1Department of Clinical Microbiology, F82, Karolinska University Hospital, Huddinge, SE-141 86 Stockholm, Sweden.

Microbial Drug Resistance (Larchmont, N.Y.)
|January 11, 2008
PubMed

Insights

Multiple methicillin-resistant Staphylococcus aureus (MRSA) clones, not a single strain, caused outbreaks in Stockholm. Hospital MRSA strains were often multidrug-resistant, while community strains carried Panton-Valentine leukocidin genes.

Area of Science:

  • Microbiology
  • Epidemiology
  • Infectious Diseases

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) infections increased in southern Stockholm starting in 2000.
  • Understanding the molecular epidemiology of MRSA is crucial for controlling its spread.

Purpose of the Study:

  • To analyze the molecular epidemiology of MRSA infections in southern Stockholm between 2000 and 2003.
  • To identify the specific MRSA clones responsible for outbreaks and their characteristics.

Main Methods:

  • Analysis of 181 newly detected MRSA patients from 2000-2003.
  • Antibiotic susceptibility testing.
  • Molecular typing: pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST).
  • Detection of Panton-Valentine leukocidin (PVL) genes.

Main Results:

  • No single MRSA clone dominated; multiple clones caused limited outbreaks.
  • Hospital outbreaks involved STs 22, 239, 247, 8, and 45, often multidrug-resistant.
  • Community MRSA was primarily ST 80, usually not multidrug-resistant.
  • PVL genes were common in community MRSA, except for ST 150 found in homeless individuals.

Conclusions:

  • MRSA outbreaks in Stockholm were driven by diverse clones, with distinct patterns in hospitals and the community.
  • Hospital-acquired MRSA clones were frequently multidrug-resistant, whereas community-acquired MRSA often harbored PVL genes.
  • The findings highlight the need for clone-specific surveillance and control strategies for MRSA.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...